PWM
NUVB icon

Perigon Wealth Management’s Nuvation Bio NUVB Stock Holding History

Perigon Wealth Management’s Portfolio NUVB Stock Details NUVB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$387K Sell
68,167
-157
-0.2% -$767 0.01% 1000
2026
Q1 		$293K Buy
68,324
+177
+0.3% +$986 0.01% 1030
2025
Q4 		$611K Buy
+68,147
New +$422K 0.01% 700

Other funds holding NUVB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
OFM
Omega Fund Management Boston, Massachusetts $186M AUM 155.23% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DFO
Duquesne Family Office New York $5.21B AUM 87.01% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Perigon Wealth Management's NUVB Position: Q2 2026 in Review

Perigon Wealth Management reduced its Nuvation Bio (NUVB) stake by 0.23% in Q2 2026, selling an estimated $767 and leaving 68,167 shares worth $387K. The position accounts for 0.01% of the portfolio, ranked #1000.

Perigon Wealth Management first reported a position in NUVB in Q4 2025 and has held it in 3 quarters since. The position peaked at $611K in Q4 2025. 244 funds tracked by Wall St. Rank hold NUVB as of Q2 2026.

  • Perigon Wealth Management held 68,167 shares of Nuvation Bio worth $387K as of Q2 2026.
  • Perigon Wealth Management sold 157 Nuvation Bio shares in Q2 2026, an estimated $767.
  • Nuvation Bio made up 0.01% of Perigon Wealth Management's portfolio in Q2 2026, its #1000 holding.
  • Perigon Wealth Management first reported a position in Nuvation Bio in Q4 2025 and has held it in 3 quarters since.
  • Perigon Wealth Management's Nuvation Bio position peaked at $611K in Q4 2025.
  • 244 funds tracked by Wall St. Rank held Nuvation Bio as of Q2 2026.

Based on Perigon Wealth Management's 13F filing for Q2 2026, filed 7 Aug 2026.